Neohesperidin Alleviates Ferroptosis in Doxorubicin‐Induced Cardiotoxicity via Mettl3‐ m 6 A ‐Nrf2 Signaling
Phytotherapy Research · 2026-11 · 40 (11) · 6748-6766
DOI: 10.1002/ptr.70458 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, online erschienen am 23.09.2026. Verfasst von Ruijia Wen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China. Hauptthemen laut MEDLINE: Hesperidin, NF-E2-Related Factor 2, Cardiotoxicity, Doxorubicin. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Science Project of the First Affiliated Hospital of Guangzhou University of Chinese Medicine, Incubation Program for the Science and Technology Development of Chinese Medicine Guangdong Laboratory.
Abstract (Originalsprache)
Doxorubicin (DOX) has antitumor efficacy, but its clinical application is restricted by multiple side effects, especially cardiotoxicity. Neohesperidin, a flavonoid in citrus fruits, has various health benefits. The aim of this study was to explore the cardioprotective effects and mechanisms of neohesperidin against DOX‐induced cardiotoxicity (DIC). The study used DOX‐treated mice to evaluate cardiac function and cardiomyocyte injury. In addition, primary cardiomyocytes treated with DOX were used to measure cell viability and death. FIN56, a ferroptosis inhibitor, was used to test the relationship between neohesperidin's beneficial effect and ferroptosis. Mechanistic investigations were carried out to explore the role of N6‐methyladenosine (m 6 A) levels, nuclear factor erythroid‐2‐related factor 2 (Nrf2) expression, and Methyltransferase‐like 3 (Mettl3) in the cardioprotective effect of neohesperidin. Overexpression and knockdown of Mettl3 were also performed to confirm its role in the cardioprotective effect. Neohesperidin attenuated cardiac function and cardiomyocyte injury in DOX‐treated mice. It alleviated DOX‐induced oxidative stress by reducing reactive oxygen species and malondialdehyde levels and increasing superoxide dismutase and glutathione levels, restoring ATP production. In DOX‐treated primary cardiomyocytes, neohesperidin increased cell viability and decreased cell death. FIN56 abolished the beneficial effect of neohesperidin. Mechanistically, neohesperidin decreased m 6 A levels, leading to increased Nrf2 expression. Nrf2 activation was related to the inhibition of Mettl3, an m 6 A “writer,” which protected cardiomyocytes against DOX‐induced ferroptosis. Overexpressing Mettl3 reversed the cardioprotective effects of neohesperidin and diminished its benefits on ferroptosis. These findings suggest that neohesperidin exerts a cardioprotective effect against DIC by inhibiting ferroptosis. This effect is achieved by regulating the Mettl3‐m 6 A‐Nrf2 signaling pathway, indicating the therapeutic potential of neohesperidin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
- The First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
- Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
- School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
ORCID-Profile: Ruijia Wen, Xin Dong
Förderung
- National Natural Science Foundation of China
- Science Project of the First Affiliated Hospital of Guangzhou University of Chinese Medicine
- Incubation Program for the Science and Technology Development of Chinese Medicine Guangdong Laboratory
- National Science and Technology Major Project of the Ministry of Science and Technology of China
- GuangDong Basic and Applied Basic Research Foundation
- National Science and Technology Major Project
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Wen, R., Dong, X., Zhuang, H., Huang, Y., Wang, M., Zhang, Z., Chen, J., Wang, W., Li, C., & Wang, J. (2026). Neohesperidin Alleviates Ferroptosis in Doxorubicin‐Induced Cardiotoxicity via Mettl3‐ m 6 A ‐Nrf2 Signaling. Phytotherapy Research, 40(11), 6748-6766. https://doi.org/10.1002/ptr.70458
Vancouver
Wen R, Dong X, Zhuang H, Huang Y, Wang M, Zhang Z, et al. Neohesperidin Alleviates Ferroptosis in Doxorubicin‐Induced Cardiotoxicity via Mettl3‐ m 6 A ‐Nrf2 Signaling. Phytotherapy Research. 2026;40(11):6748-6766. doi:10.1002/ptr.70458
BibTeX
@article{Wen2026,
author = {Wen, Ruijia and Dong, Xin and Zhuang, Haowen and Huang, Yusheng and Wang, Mengyuan and Zhang, Zhongzheng and Chen, Jinhong and Wang, Wei and Li, Chun and Wang, Junyan},
title = {Neohesperidin Alleviates Ferroptosis in Doxorubicin‐Induced Cardiotoxicity via Mettl3‐ m 6 A ‐Nrf2 Signaling},
journal = {Phytotherapy Research},
year = {2026},
volume = {40},
number = {11},
pages = {6748--6766},
doi = {10.1002/ptr.70458}
}
EUVIMED